Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cooke, Kenneth R  [Clear All Filters]
2022
Ktena YP, Koldobskiy MA, Barbato MI, Fu H-H, Luznik L, Llosa NJ, Haile A, Klein OR, Liu C, Gamper CJ, et al. Donor T-cell DNMT3a regulates alloreactivity in murine models of hematopoietic stem cell transplantation. J Clin Invest. 2022.
2021
Metheny L, Eid S, Wuttisarnwattana P, Auletta JJ, Liu C, Van Dervort A, Paez C, Lee ZHong, Wilson D, Lazarus HM, et al. Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity following experimental, allogeneic bone marrow transplantation. Stem Cells. 2021.
2020
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CAnn, Swinnen LJ, Imus P, Borrello I, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020;4(8):1770-1779.
2018
Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, et al. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018.
2015
Holter-Chakrabarty JL, Pierson N, Zhang M-J, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, et al. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplant for Patients with Acute Leukemia. Biol Blood Marrow Transplant. 2015.